Vijaya Diagnostic (VIJAYA) | Stock Overview & Key Data
Vijaya Diagnostic Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,427.80 on June 5, 2026
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vijaya Diagnostic
VIJAYA
|
109.64B Mid-cap | -1.87% | -3.46% | 36.74% | 29.74% | 23.10% | 35.44% | 216.81% | 105.30% | 105.30% | 105.30% | 105.30% |
|
Dr. Lal PathLabs
LALPATHLAB
|
238.92B Large-cap | 4.53% | 0.82% | 20.51% | 13.04% | 7.03% | 8.45% | 58.06% | 0.84% | 257.00% | 257.46% | 257.46% |
|
Sai Life Sciences
SAILIFE
|
217.06B Large-cap | 1.11% | 10.73% | 23.70% | 32.85% | 34.17% | 58.19% | 73.11% | 73.11% | 73.11% | 73.11% | 73.11% |
|
Syngene
SYNGENE
|
169.26B Mid-cap | 0.89% | -0.12% | 10.57% | -31.32% | -30.25% | -29.79% | -38.23% | -19.99% | 131.38% | 186.56% | 186.56% |
|
Metropolis
METROPOLIS
|
97.90B Mid-cap | -0.71% | -0.56% | 14.36% | 9.60% | 10.90% | 24.89% | 56.99% | -23.14% | 118.75% | 118.75% | 118.75% |
|
Thyrocare
THYROCARE
|
62.88B Mid-cap | -1.06% | 15.89% | 48.78% | 23.90% | 19.90% | 55.33% | 231.85% | 23.21% | 170.47% | 153.71% | 153.71% |
Ownership & Short Interest
Calculate Your Vijaya Diagnostic Investment Returns
Long-Term Investment Performance Analysis
Vijaya Diagnostic stock price in Sep 2021 was ₹627.00, A ₹1,000.00 lump sum investment in Vijaya Diagnostic made 4 years ago would be worth approximately ₹2,046.57 today, representing a strong return of 104.66%. This translates to an annualized return (CAGR) of 16.26%.
4 Years 9 Months Investment Scenario (Sep 2021 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is VIJAYA's 52-week high and low?
- In the last 52 weeks, Vijaya Diagnostic reached a high of ₹1,427.80 (on June 5, 2026) and a low of ₹848.00 (on March 30, 2026).
- What is the market cap and P/E ratio for VIJAYA?
- Curious about Vijaya Diagnostic's size and valuation? Its market capitalization stands at 109.64B. When it comes to valuation, the P/E ratio (trailing twelve months) is 67.41, and the forward P/E (looking ahead) is 50.66.
- Does VIJAYA pay dividends? If so, what's the yield?
- Yes, Vijaya Diagnostic is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.30%, and the company has paid an average of ₹1.67 per share annually over the past 3 years.
- Who are Vijaya Diagnostic's main competitors or similar companies to consider before investing?
When looking at Vijaya Diagnostic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB238.92B Healthcare Diagnostics & Research 8.45% 58.06% Sai Life Sciences
SAILIFE217.06B Healthcare Diagnostics & Research 58.19% 73.11% Syngene
SYNGENE169.26B Healthcare Diagnostics & Research -29.79% -38.23% Metropolis
METROPOLIS97.90B Healthcare Diagnostics & Research 24.89% 56.99% Thyrocare
THYROCARE62.88B Healthcare Diagnostics & Research 55.33% 231.85% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vijaya Diagnostic Centre Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Vijaya Diagnostic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.90%, the Debt to Equity ratio from the most recent quarter is 42.22, and its Gross Profit Margin stands at 88.29%.
- What is the recent revenue and earnings growth for VIJAYA?
- Looking at Vijaya Diagnostic's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 21.40%, and quarterly earnings saw a YoY growth of 22.80%.
- How much of VIJAYA stock is held by insiders and institutions?
- Wondering who owns Vijaya Diagnostic stock? Company insiders (like executives and directors) hold about 52.51% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 34.14%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.